Prognostic Evaluation of Supraventricular Arrhythmias in Athletes

  • A. Biffi
  • G. Piovano
  • L. Verdile
  • F. Fernando


Supraventricular arrhythmias (SA) affect a large number of subjects. They are generally considered to be benign and are still largely treated by anti arrhythmic drugs. In rare cases and by certain specific mechanisms not only in Wolff-Parkinson-White syndrome (W-P-W), SA may cause sudden cardiac death [1]. Atrial fibrillation is certainly the most common arrhythmia in clinical practice, its prevalence being about 0.2–9% in the adult population, depending on age [2]. However, to date not much is known about the electrophysiologic mechanism of atrial fibrillation, with consequent objective difficulties in defining the vulnerable parameters.


Atrial Fibrillation Atrial Tachycardia Supraventricular Arrhythmia Slow Pathway Junctional Tachycardia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wang Y, Scheinman MM, Chien WW et al (1991) Patients with supraventricular tachycardia presenting with aborted sudden death: mechanism and long-term follow-up. J. Am Coll Cardiol 18:1711PubMedCrossRefGoogle Scholar
  2. 2.
    Kannel WB, Wolf PA (1992) Epidemiology of atrial fibrillation. In: Falk RH, Podrid PJ (eds) Atrial Fibrillation: Mechanisms and Management. New York, Raven Press Ltd. 81Google Scholar
  3. 3.
    Gallagher JJ, Svenson RH, Kasell JH et al (1982) Catheter technique for closed-chest ablation of the atrio-ventricular conduction system. N Engl J Med 306:194PubMedCrossRefGoogle Scholar
  4. 4.
    Furlanello F, Bertoldi A, Dallago M et al (1994) Atrial fibrillation in top-level athletes. In Olsson SB, Allessie MA, Campbell RWF (eds) Atrial Fibrillation: mechanisms and therapeutic strategies. Futura Publishing Co Inc, Armonk, NYGoogle Scholar
  5. 5.
    Delise P, Bonso A, Coro’ L et al (1992) Electrophysiologic substrates of idiopathic atrial fibrillation in the general population and in athletes. New Trends Arrhyth 8:719Google Scholar
  6. 6.
    Biffi A, Ammirati F, Caselli G et al (1993) Usefulness of transesophageal pacing during exercise for evaluating palpitations in top-level athletes. Am J Cardiol 72:922PubMedCrossRefGoogle Scholar
  7. 7.
    Timmermans C, Smeets J, Rodriguez LM et al (1995) Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol 76:492.PubMedCrossRefGoogle Scholar
  8. 8.
    Coumel P, Attuel P, Lavallee JP et al (1978) Syndrome d’arythmie auriculaire d’origine vagale. Arch Mal Coeur 71:645PubMedGoogle Scholar
  9. 9.
    Zipes DP, Mihalick MJ, Robbins GT (1974) Effects of selective vagal and stellate ganglion stimulation on atrial refractoriness. Cardiovasc Res 8:647PubMedCrossRefGoogle Scholar
  10. 10.
    Badeer HS (1980) Cardiovascular adaptations in the trained athlete. In: Lubich T, Venerando A. (eds) Proceedings of the International Conference on Sports Cardiology, Rome 1978, Gaggi Bologna, p 3Google Scholar
  11. 11.
    Zeppilli P, Frustaci A (1993) Utilita’, limiti ed indicazioni della biopsia miocardica negli sportivi. Int J Sports Cardiol 2:275Google Scholar
  12. 12.
    Crijns HJGM, Van Vijk M, Van Gilst WH et al (1988) Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. Eur Heart J 9:634PubMedGoogle Scholar
  13. 13.
    Pritchett ELC, McCarthy EA, Wilkinson WE (1991) Propafenone treatment of symptomatic paroxysmal supraventricular arhhythmias. Ann Inter Med 114:539CrossRefGoogle Scholar
  14. 14.
    Waldo AL (1987) Mechanism of atrial fibrillation, atrial flutter and ectopic atrial tachycardia: a brief review. Circulation 75:37Google Scholar
  15. 15.
    Josephson ME (1993) Clinical cardiac electrophysiology. Lea and Febiger, 182Google Scholar
  16. 16.
    Scheinman MM (1985) Atrioventricular nodal or atriojunctional reentrant tachycardia. J Am Coll Cardiol 6:1393PubMedCrossRefGoogle Scholar
  17. 17.
    Santini M, Ansalone G, Cacciatore G, Turitto G (1990) Transesophageal pacing. PACE 13:1298PubMedCrossRefGoogle Scholar
  18. 18.
    Delise P, D’Este D, Bonso A et al (1989) Utilita dello studio elettrofisologico transesofageo durante test ergometrico nella valutazione delle tachicardie parossistiche sopraventricolari insorgenti sotto sforzo. G Ital Cardiol 19:1094PubMedGoogle Scholar
  19. 19.
    Brembilla-Perrot B, Terrier de la Chaise A, Pichene, M et al (1989) Isoprenaline as an aid to the conduction of the catecholamine-dependent supraventricular tachycardias. Br Heart J 61:348PubMedCrossRefGoogle Scholar
  20. 20.
    Mazgalev T, Dreifus LS, Michelson EL et al (1986) Vagally induced hyperpolarization in atrioventricular node. Am J Physiol 251:H631-H643Google Scholar
  21. 21.
    Kuck KH, Schluter M (1994) Junctional tachycardia and the role of catheter ablation. Lancet 8857:1386Google Scholar
  22. 22.
    Lee MA, Morady F, Kadish A et al (1991) Catheter modification of the atrioventricular junction with radiofrequncy energy for control of atrioventricular nodal reentry tachycardia. Circulation 83:827PubMedCrossRefGoogle Scholar
  23. 23.
    Jazayeri Mr, Hempe SL, Sra JS et al (1992) Selective transcatheter ablation of the fast and slow pathways using radiofrequency energy in patients with atrioventricular nodal reentry tachycardia. Circulation 85:1318PubMedCrossRefGoogle Scholar
  24. 24.
    Wu D, Yeh SJ, Wang CC et al (1992) Nature of dual atrioventricular node pathways and the tachycardia circuit as defined by radiofrequency ablation technique. J Am Coll Cardiol 20:884PubMedCrossRefGoogle Scholar
  25. 25.
    Jackman WM, Beckman KJ, McClelland JH et al (1992) Treatment of supraventricular tachycardia due to atrioventricular nodal reentry tachycardia by radiofrequency ablation of slow-pathway conduction. N Engl J Med 327:313PubMedCrossRefGoogle Scholar
  26. 26.
    Haissaguerre M, Gaita F, Fischer B et al (1992) Elimination of atrioventricular nodal reentry tachycardia using discrete slow potentials to guide application of radiofrequency energy. Circulation 85:2162PubMedCrossRefGoogle Scholar
  27. 27.
    Kay GN, Epstein AE, Dailey et al (1992) Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentry tachycardia: evidence for involvement of perinodal myocardium with the reentrant circuit. Circulation 85:1675PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1997

Authors and Affiliations

  • A. Biffi
    • 1
  • G. Piovano
    • 1
  • L. Verdile
    • 1
  • F. Fernando
    • 1
  1. 1.Department of Medicine, Institute of Sport SciencesCONIRomeItaly

Personalised recommendations